Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Ising

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Genome Biology|December 18, 2015
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Addiction Biology|October 19, 2011
Genome-wide significant association between alcohol dependence and a variant in the ADH gene clusterJosef Frank, Sven Cichon, Jens Treutlein, et al.
Science Signaling|November 26, 2015
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetineNils C Gassen, Gabriel R Fries, Anthony S Zannas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 3, 2012
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levelsStefan Kloiber, Stephan Ripke, Martin A Kohli, et al.
BMC Psychiatry|June 11, 2015
Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocolLars O White, Annette M Klein, Clemens Kirschbaum, et al.
Frontiers in Psychiatry|July 3, 2023
The associations of Positive and Negative Valence Systems, Cognitive Systems and Social Processes on disease severity in anxiety and depressive disordersBernd R Förstner, Sarah Jane Böttger, Alexander Moldavski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
Journal of Affective Disorders|November 13, 2013
Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contributionPanagiotis Ferentinos, Margarita Rivera, Marcus Ising, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Genome Biology|December 18, 2015
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signalingAnthony S Zannas, Janine Arloth, Tania Carrillo-Roa, et al.
Addiction Biology|October 19, 2011
Genome-wide significant association between alcohol dependence and a variant in the ADH gene clusterJosef Frank, Sven Cichon, Jens Treutlein, et al.
Science Signaling|November 26, 2015
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetineNils C Gassen, Gabriel R Fries, Anthony S Zannas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 3, 2012
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levelsStefan Kloiber, Stephan Ripke, Martin A Kohli, et al.
BMC Psychiatry|June 11, 2015
Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocolLars O White, Annette M Klein, Clemens Kirschbaum, et al.
Frontiers in Psychiatry|July 3, 2023
The associations of Positive and Negative Valence Systems, Cognitive Systems and Social Processes on disease severity in anxiety and depressive disordersBernd R Förstner, Sarah Jane Böttger, Alexander Moldavski, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
Journal of Affective Disorders|November 13, 2013
Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contributionPanagiotis Ferentinos, Margarita Rivera, Marcus Ising, et al.
Pageof 15